BioCryst Pharmaceuticals
BCRX
#4942
Rank
HK$15.03 B
Marketcap
HK$58.45
Share price
-2.10%
Change (1 day)
6.99%
Change (1 year)

EPS for BioCryst Pharmaceuticals (BCRX)

EPS in 2026 (TTM): -HK$10.65

According to BioCryst Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -HK$10.59. In 2025 the company made an earnings per share (EPS) of HK$9.81 an increase over its 2024 EPS that were of -HK$3.37.

EPS history for BioCryst Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$10.65-208.56%
2025HK$9.81-390.7%
2024-HK$3.37-63.56%
2023-HK$9.26-11.28%
2022-HK$10.4329.13%
2021-HK$8.08-4.63%
2020-HK$8.4710.2%
2019-HK$7.690%
2018-HK$7.6925.64%
2017-HK$6.124%
2016-HK$5.8827.12%
2015-HK$4.63-13.24%
2014-HK$5.3423.64%
2013-HK$4.32-30.38%
2012-HK$6.20

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
-HK$24.32 129.63%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$22.57-313.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-HK$20.63 94.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
-HK$1.57-85.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-HK$11.93 12.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$34.13 222.22%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-HK$3.45-67.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-HK$24.95 135.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-HK$39.54 273.33%๐Ÿ‡บ๐Ÿ‡ธ USA